Prevention of Pneumocystis carinii pneumonia relapse by aerosolised pentamidine, 60 mg biweekly, using an Acorn System 22 nebuliser

B N Jensen, T L Nielsen, B Lerche, T H Jensen, V Backer, L Mathiesen, J O Nielsen, P Skinhøj

Abstract

The effectiveness of biweekly administration of 60 mg aerosolised pentamidine (AP) as secondary prophylaxis against relapse of Pneumocystis carinii pneumonia (PCP) was investigated in 45 male AIDS patients. The nebuliser used was an Acorn System 22. In total the patients received AP for a mean period of 13.8 months (3.4-28.8). Six episodes of recurrent PCP were recorded. Relapse per full year of treatment on AP was 12%.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Infectious Diseases
Vol/bind22
Udgave nummer5
Sider (fra-til)533-6
Antal sider4
ISSN0036-5548
DOI
StatusUdgivet - 1990
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Prevention of Pneumocystis carinii pneumonia relapse by aerosolised pentamidine, 60 mg biweekly, using an Acorn System 22 nebuliser'. Sammen danner de et unikt fingeraftryk.

Citationsformater